106 related articles for article (PubMed ID: 29733987)
1. Use of Bone Morphogenetic Protein-2 in Vertebral Column Tumor Surgery: A National Investigation.
De la Garza Ramos R; Nakhla J; Echt M; Gelfand Y; Altschul DJ; Cho W; Kinon MD; Yassari R
World Neurosurg; 2018 Sep; 117():e17-e21. PubMed ID: 29733987
[TBL] [Abstract][Full Text] [Related]
2. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.
Hofstetter CP; Hofer AS; Levi AD
J Neurosurg Spine; 2016 Mar; 24(3):457-75. PubMed ID: 26613283
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011.
Singh K; Nandyala SV; Marquez-Lara A; Fineberg SJ
Spine (Phila Pa 1976); 2014 Mar; 39(6):491-6. PubMed ID: 24365905
[TBL] [Abstract][Full Text] [Related]
4. Bone graft options for spinal fusion following resection of spinal column tumors: systematic review and meta-analysis.
Elder BD; Ishida W; Goodwin CR; Bydon A; Gokaslan ZL; Sciubba DM; Wolinsky JP; Witham TF
Neurosurg Focus; 2017 Jan; 42(1):E16. PubMed ID: 28041327
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with use of bone morphogenetic protein during pediatric spinal fusion surgery: an analysis of 4817 patients.
Jain A; Kebaish KM; Sponseller PD
J Bone Joint Surg Am; 2013 Jul; 95(14):1265-70. PubMed ID: 23864174
[TBL] [Abstract][Full Text] [Related]
6. Impact of bone morphogenetic proteins on frequency of revision surgery, use of autograft bone, and total hospital charges in surgery for lumbar degenerative disease: review of the Nationwide Inpatient Sample from 2002 to 2008.
Dagostino PR; Whitmore RG; Smith GA; Maltenfort MG; Ratliff JK
Spine J; 2014 Jan; 14(1):20-30. PubMed ID: 23218827
[TBL] [Abstract][Full Text] [Related]
7. Off-label use of bone morphogenetic proteins in the United States using administrative data.
Ong KL; Villarraga ML; Lau E; Carreon LY; Kurtz SM; Glassman SD
Spine (Phila Pa 1976); 2010 Sep; 35(19):1794-800. PubMed ID: 20700081
[TBL] [Abstract][Full Text] [Related]
8. Bone Morphogenetic Proteins in Pediatric Spinal Arthrodesis: A Statewide Analysis of Trends and Outcome of Utilization.
Nwachukwu BU; Schairer WW; Pan T; Widmann RF; Blanco JS; Green DW; Lyman S; Dodwell ER
J Pediatr Orthop; 2017 Sep; 37(6):e369-e374. PubMed ID: 28060176
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures.
Cahill KS; Chi JH; Day A; Claus EB
JAMA; 2009 Jul; 302(1):58-66. PubMed ID: 19567440
[TBL] [Abstract][Full Text] [Related]
10. Use of Recombinant Bone Morphogenetic Protein Is Associated With Reduced Risk of Reoperation After Spine Fusion for Adult Spinal Deformity.
Paul JC; Lonner BS; Vira S; Kaye ID; Errico TJ
Spine (Phila Pa 1976); 2016 Jan; 41(1):E15-21. PubMed ID: 26335682
[TBL] [Abstract][Full Text] [Related]
11. RhBMP-2 is superior to iliac crest bone graft for long fusions to the sacrum in adult spinal deformity: 4- to 14-year follow-up.
Kim HJ; Buchowski JM; Zebala LP; Dickson DD; Koester L; Bridwell KH
Spine (Phila Pa 1976); 2013 Jun; 38(14):1209-15. PubMed ID: 23392417
[TBL] [Abstract][Full Text] [Related]
12. A population-based review of bone morphogenetic protein: associated complication and reoperation rates after lumbar spinal fusion.
Savage JW; Kelly MP; Ellison SA; Anderson PA
Neurosurg Focus; 2015 Oct; 39(4):E13. PubMed ID: 26424337
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
[TBL] [Abstract][Full Text] [Related]
14. The Rise and Fall of Bone Morphogenetic Protein 2 Throughout the United States.
Beschloss AM; DiCindio CM; Lombardi JS; Shillingford JN; Laratta JL; Holderread B; Louie P; Pugely AJ; Sardar Z; Khalsa AS; Arlet VM; Saifi C
Clin Spine Surg; 2022 Jul; 35(6):264-269. PubMed ID: 35180720
[TBL] [Abstract][Full Text] [Related]
15. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111
[TBL] [Abstract][Full Text] [Related]
16. Does bone morphogenetic protein increase the incidence of perioperative complications in spinal fusion? A comparison of 55,862 cases of spinal fusion with and without bone morphogenetic protein.
Williams BJ; Smith JS; Fu KM; Hamilton DK; Polly DW; Ames CP; Berven SH; Perra JH; Knapp DR; McCarthy RE; Shaffrey CI;
Spine (Phila Pa 1976); 2011 Sep; 36(20):1685-91. PubMed ID: 21897187
[TBL] [Abstract][Full Text] [Related]
17. Spinal fusion for pediatric neuromuscular scoliosis: national trends, complications, and in-hospital outcomes.
Rumalla K; Yarbrough CK; Pugely AJ; Koester L; Dorward IG
J Neurosurg Spine; 2016 Oct; 25(4):500-508. PubMed ID: 27203810
[TBL] [Abstract][Full Text] [Related]
18. Hospital outcomes and complications of anterior and posterior cervical fusion with bone morphogenetic protein.
Fineberg SJ; Ahmadinia K; Oglesby M; Patel AA; Singh K
Spine (Phila Pa 1976); 2013 Jul; 38(15):1304-9. PubMed ID: 23462577
[TBL] [Abstract][Full Text] [Related]
19. Does recombinant human bone morphogenetic protein-2 use in adult spinal deformity increase complications and are complications associated with location of rhBMP-2 use? A prospective, multicenter study of 279 consecutive patients.
Bess S; Line BG; Lafage V; Schwab F; Shaffrey CI; Hart RA; Boachie-Adjei O; Akbarnia BA; Ames CP; Burton DC; Deverin V; Fu KM; Gupta M; Hostin R; Kebaish K; Klineberg E; Mundis G; O'Brien M; Shelokov A; Smith JS;
Spine (Phila Pa 1976); 2014 Feb; 39(3):233-42. PubMed ID: 24477081
[TBL] [Abstract][Full Text] [Related]
20. Acute epidural lipedema: a novel entity and potential complication of bone morphogenetic protein use in lumbar spine fusion.
Merrick MT; Hamilton KD; Russo SS
Spine J; 2013 Oct; 13(10):e15-9. PubMed ID: 23800822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
